Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 5/20 | 0.35 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25879273 | 0.87 | OGA (0.34) | OGA | |
| SCHEMBL1315967 | 0.82 | OGA (0.34) | OGA | |
| SCHEMBL1706888 | 0.77 | — | — | |
| SCHEMBL10516159 | 0.77 | — | — | |
| SCHEMBL10516169 | 0.77 | — | — | |
| SCHEMBL10516768 | 0.77 | — | — | |
| SCHEMBL13175208 | 0.76 | OGA (0.34) | OGASI | |
| SCHEMBL5052791 | 0.75 | — | — | |
| SCHEMBL1864394 | 0.75 | — | — | |
| SCHEMBL924098 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2441761-A1 | Oxetane-containing vinyl ether compounds and polymerizable compositions | Daicel Chemical Industries, Ltd. (JP) | 2012-04-18 | — | — | EP | disclosed |
| US-7985866-B2 | Oxetane-containing vinyl ether compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-07-26 | — | — | US | disclosed |
| EP-2233475-A1 | Epoxycyclohexane vinyl ether compounds and their use in polymerizable compositions | Daicel Chemical Industries, Ltd. (JP) | 2010-09-29 | — | — | EP | disclosed |
| US-20090131498-A1 | Enantioselective Synthesis of Merrilactone and Its Analogs | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2009-05-21 | — | — | US | disclosed |
| US-20090131498-A1 | Enantioselective Synthesis of Merrilactone and Its Analogs | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2009-05-21 | — | — | US | disclosed |
| US-20080234455-A1 | Vinyl ether compounds and polymerizable compositions | DAICEL CHEMICAL INDUSTRIES, LTD. | 2008-09-25 | — | — | US | disclosed |
| EP-1972622-A2 | Vinyl ether compounds and polymerizable compositions | Daicel Chemical Industries, Ltd. (JP) | 2008-09-24 | — | — | EP | disclosed |
| EP-1172400-B1 | THERMOPLASTIC RESIN FILM WITH SATISFACTORY PRINTABILITY | YUPO CORP (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-6586106-B2 | Ink transfer, adhesion and aging stability, and being satisfactory in back ghost when offset printing using oxidation polymerization type ink is performed on both faces | YUPO CORPORATION (JP) | 2003-07-01 | — | — | US | disclosed |
| US-20020054991-A1 | Thermoplastic resin film satisfactory in printability | YUPO CORPORATION (JP) | 2002-05-09 | — | — | US | disclosed |
| EP-1172400-A1 | THERMOPLASTIC RESIN FILM WITH SATISFACTORY PRINTABILITY | Yupo Corporation (JP) | 2002-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234455-A1 | Vinyl ether compounds and polymerizable compositions | CBR1, ECH1, VDAC1 | OGA 2012/4885SI 4594/4885TDP1 3616/4885 |
| US-20090131498-A1 | Enantioselective Synthesis of Merrilactone and Its Analogs | PMP22, CYP51A1, NTRK1 | OGA 1535/4885SI 2593/4885TDP1 2871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.